Statistics
Publications
2
Citations
88
H-Index
2
Active since
2019
Affiliations
Yebin Lu is an author at The University of Texas MD Anderson Cancer Center specializing in ret gene mutations, biochar production, and ret inhibitors.
Publications per year
2019–2024
2
2
TPX-0046 is a novel and potent RET/SRC inhibitor for RET-driven cancers
Alexander Drilon, Evan Rogers, Dayong Zhai et al. · Annals of Oncology · 2019 · 57 citations
Medicine, Oncology, Pharmacology +12
1–2 of 2